LABCORP HOLDINGS INC. (LH)
Services-Medical Laboratories · Services-Medical Laboratories · NYSE
$330.44
+2.56%
Investingg Score
51.5 / 100
Hold
Business overview
- Gross margin stands at 28.8%.
- Operating margin is reported at 9.9%.
- Free cash flow margin reaches 8.6%.
These margins reflect steady operational efficiency within the medical laboratories sector.
Financial health
- Free cash flow yield is 4.4%.
- Balance sheet pillar score is recorded at 44.
- Overall Investingg Score is 51.5 with a Hold verdict.
These metrics indicate stable cash generation capabilities alongside moderate overall financial health.
- Gross Margin
- 28.8%
- Operating Margin
- 9.9%
- Current Ratio
- 1.4x
- Debt / Equity
- 0.59
- Free Cash Flow (TTM)
- $1.2B
- Interest Coverage
- 6x
Valuation
- P/E ratio is 25.26.
- Forward P/E ratio is 16.72.
- EV to EBITDA is 13.76.
- Price-to-sales ratio sits at 1.89.
These valuation multiples suggest that the stock is moderately priced relative to its near-term earnings outlook.
- P/E (TTM)
- 25.3x
- Forward P/E
- 16.7x
- Price / Sales
- 1.9x
- EV / EBITDA
- 13.8x
- FCF Yield
- 4.4%
Key risks
- Data unavailable for specific risk factors in the provided dataset.
- Uncertainty remains regarding the sustainability of the current 18.3% EPS growth rate.
- Technical indicators like an RSI of 66.89 could suggest potential short-term overbought conditions.
Market cap $27.2B · data as of 2026-08-19
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze LH with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.